Loading organizations...
ARTIRIA Medical is a Lausanne, Switzerland-based medical technology company that develops micro-actuated guidewires and catheters for minimally invasive neurointerventional procedures. The company focuses on manufacturing articulating neurovascular devices that enable real-time deflection and micromotion deep within brain arteries to improve surgical navigation during stroke and aneurysm treatments. Operating with a team of seven employees, the startup has raised approximately $13.25 million in total venture capital and grant funding to support clinical validation. The firm recently achieved a major regulatory milestone by securing FDA clearance for its flagship deflectable guidewire product ahead of its first-in-human clinical use. Financial backers and institutional partners supporting the enterprise include 4FO Venture Partners, Zürcher Kantonalbank, Venture Kick, and the Wyss Center for Bio and Neuroengineering. ARTIRIA Medical was founded in 2019 as an EPFL spin-off by Guillaume Petit-Pierre and Marc Boers.
ARTIRIA Medical has raised $13.9M across 3 funding rounds.
ARTIRIA Medical has raised $13.9M in total across 3 funding rounds.
ARTIRIA Medical has raised $13.9M in total across 3 funding rounds.
ARTIRIA Medical's investors include Valentin Maxime Chenaux, Foundation for Technological Innovation, Nest Sammelstiftung, Verve Ventures, Wyss Center for Bio and Neuroengineering, Zürcher Kantonalbank, EIC Fund, Jean-Pierre Rosat, NEST, Venture Kick.
ARTIRIA Medical has raised $13.9M across 3 funding rounds. Most recently, it raised $6.6M Debt / Series A in February 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 27, 2024 | $6.6M Debt Financing | Valentin Maxime Chenaux | Foundation For Technological Innovation, Nest Sammelstiftung, Verve Ventures, Wyss Center For BIO And Neuroengineering, Zürcher Kantonalbank | Announced |
| Apr 12, 2022 | $4.1M Grant | EIC Fund | — | Announced |
| Jul 15, 2020 | $3.2M Series A | Jean Pierre Rosat | Nest Labs, Venture Kick, Verve Ventures, Zürcher Kantonalbank | Announced |
